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Background: Mutations in the bone morphogenetic protein type 2
receptor (BMPR2) are responsible for themajority of cases of heritable
pulmonary arterial hypertension (PAH). Low penetrance of BMPR2
mutation in heritable PAH, however, suggests the involvement of
second-hit elements in the pathogenesis of PAH. We have previously
reported that treatment with endothelin-1 induced in vitro increased
expression of noggin, an intrinsic bone morphogenetic protein antag-
onist, in human pulmonary artery smooth muscle cells (PA-SMCs).
Moreover, chronic exposure to hypoxia is a well-known inducer of
remodeling in pulmonary arteries. However, the potential link be-
tween chronic hypoxia exposure and noggin expression has not been
elucidated. Aims: We hypothesized that hypoxia could induce, in
PA-SMCs, the expression of endothelin-1 which could secondarily
result in the upregulation of noggin. Methods and results: Cultured
human PA-SMCs were treated for 3, 6, 24, and 48 h with the hypoxia-
mimetic agent, cobalt chloride (CoCl2; 100 μM) and gene expressions of
preproendothelin-1 (ppET1), endothelin converting enzyme-1 (ECE1)
and noggin were then evaluated by QRT-PCR. CoCl2 treatment progres-
sively increased the expressions of ppET1 and noggin, with maximal
response after 24 h and 48 h of stimulation respectively. Gene ex-
pression of ECE1 was not changed. After pretreatment or not with a
non-selective endothelin receptor antagonist (bosentan), we stimulat-
ed PA-SMCs with CoCl2 for 5 h. Gene expression of noggin signiﬁcantly
increased after CoCl2 treatment and this reaction was not changed by
pretreatment with bosentan. Conclusions: Noggin, an intrinsic bone
morphogenetic protein antagonist, was upregulated by CoCl2, indepen-
dent of hypoxia-induced endothelin-1 pathway at earlier timing (5 h).
doi:10.1016/j.lfs.2013.12.095
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Background: Increased arterial stiffness is an independent risk factor
for cardiovascular disease. The −401 T/C and insertion/deletion (I/D)
polymorphisms of estrogen receptor-alpha and angiotensin-converting
enzyme (ACE) genes are associatedwith arterial stiffness.We examined
the effect of this combination of single-nucleotide polymorphisms on
the risk for increased arterial stiffness. Methods: Our cross-sectional
study comprised 403 middle-aged and older human participants. We
determined the genotypes of −401 T/C and I/D single-nucleotide
polymorphisms in estrogen receptor-alpha and ACE by TaqMan PCR
method. We also measured arterial stiffness by brachial-ankle pulse-
wave velocity (baPWV). Subjects were divided into high arterial
stiffness and low arterial stiffness groups, with the dividing line set at
the median value of baPWV. Results: The odds ratio for the presence of
high arterial stiffness in individuals having the TT genotype of estrogen
receptor-alpha compared with those having the other genotypes (TC
and CC)was2.46.With regard to the I/D polymorphism inACE, the odds
ratio for the presence of high arterial stiffness in individuals having
the II genotype of ACE when compared with those having the other
genotypes (ID and DD) was 1.99. Interestingly, the odds ratio was 5.31
for individuals having a combination of the TT genotype of estrogen
receptor-alpha and II genotype of ACE when compared with those
having a combination of TC and CC genotypes of estrogen receptor-
alpha and ID and DD genotypes of ACE. Conclusion: We revealed that a
combination of the TT and II polymorphisms in estrogen receptor-alpha
and ACE remarkably increased the risk for elevation of arterial stiffness
in middle-aged and older humans.
doi:10.1016/j.lfs.2013.12.096
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Background: Right ventricular (RV) dilation and dysfunction after
corrected tetralogy of Fallot (c-ToF) is associated with their prognosis.
In contrast, left ventricular (LV) function has been focused as a novel
determinant of prognosis in patients with c-ToF.We aimed to assess RV
and LV volume in consideration of interaction with biventricular EF.
Methods:We studied 45 patients with repaired ToF (23males, 20.8 yrs,
range 7–49 yrs).We examined 2-dimensional and 3-dimensinoal trans-
thoracic echocardiography. To determine the severity of pulmonary
stenosis (PS), we recorded the maximum ﬂow velocity through the
pulmonary valve obtained from continuous wave Doppler measure-
ment by 2-dimensional echocardiography. The pressure gradients were
calculated from this velocity using a simpliﬁed Bernoulli's equation. RV
and LV end diastolic volume index (EDVI, ml/m2), end systolic volume
index (ml/m2), stroke volume index (ml/m2) and ejection fractions (EF)
were measured with 3-dimensional transthoracic echocardiographic
system (RV; Tomtec imaging systems, LV; 4D auto LVQ. GE Vivid E9,
Japan). Results: RVEDVi and LVEDVi measured were 80.2 ± 22.6 ml/m2
and 53.0 ± 10.1 ml/m2, respectively. RV/LV EDVI ratio (1.57 ± 0.59)
was negatively correlated with RVEF (r =−0.350, p = 0.021). In the
multivariate stepwise analysis, LVEF was associated with RV/LV EDVI
ratio and RVEF (R= 0.518). On the other hand, the degree of PS didn't
correlate with biventricular volume and function. Conclusions: LVEF
may be affected rather by RV/LV volume ratio and RVEF in the patients
with c-ToF.
doi:10.1016/j.lfs.2013.12.097
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Introduction: Pulmonary hypertension (PH) due to left heart disease
is common, and associated with increased left atrial pressure. In some
patients with PH caused by left heart failure, there is entity called ‘PH
with out of proportion’ (further increase of the pulmonary artery
pressure evoked by elevated precapillary pulmonary vasoconstriction
and vascular remodelling). The treatment of this clinical condition
is often difﬁcult. We report a markedly improved case of PH with
left ventricular dysfunction caused by coronary artery disease (CAD)
which was treated by percutaneous coronary intervention (PCI). Case
presentation: A 68-year-old man was admitted to our hospital for the
purpose of detailed examination about CAD. Outpatient examinations
including echocardiogram, treadmill exercise test and coronary com-
puted-tomography angiography suggested that he had systolic and
diastolic left heart failure because of CAD. Severe pulmonary arterial
hypertension without signiﬁcant valvular disease was also observed
by echocardiography and his systolic right ventricular pressure was
estimated to be 80 mmHg. Coronary angiography showed signiﬁcant
stenosis of right coronary artery (diffuse in mid to distal portion)
and left anterior descending artery (proximal portion). Right heart
catheterization was performed before percutaneous coronary interven-
tion and revealed severe PH with out-of-proportion physiology. He
underwent elective percutaneous coronary intervention for these
two vessels. After these interventions, pulmonary wedge pressure,
pulmonary artery pressure, and pulmonary vascular resistance were
apparently improved, even though in and out valance was almost
equal during procedure. Conclusion: Ischemic left ventricular diastolic
dysfunction showed an important impact to the severe pulmonary
resistance elevation. Coronary revascularization would be the ﬁrst line
therapy for PH patients with CAD.
doi:10.1016/j.lfs.2013.12.098
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Background: Morning hypertension (HT) has been identiﬁed as a
major cardiovascular risk, however, the population susceptible to
morning hypertension is unknown. This study aimed to clarify the
relationship between morning hypertension and diabetes or obesity
in a large scale population. Methods and results: A total of 2554 out-
patients with hypertension at 101 clinics or hospitals were enrolled.
Their clinic blood pressures (BPs) and 2-week awakening BPs were
recorded. The mean ofﬁce BP N140/90 mmHg or awakening BP N135/
85 mmHg was considered as HT. Subjects were classiﬁed into four
groups on the basis of ofﬁce BP and home BP, normal BP, white coat
HT, masked HT and sustained HT. The morning BP (mm Hg) elevated
signiﬁcantly and progressively in the order of normal glucose tolerance
(134.1 ± 12.2), impaired glucose tolerance (135.4 ± 13.1), and dia-
betic patients (137.5 ± 11.5) (P b 0.0001). Incidence of morning HT
also increased signiﬁcantly and progressively in the same order (53.4%,
55.6%, 66.4%, P b 0.0001). Moreover, the morning BP of obese diabetic
patients was signiﬁcantly higher than that of non-obese and non-
diabetic patients (138.8 ± 10.5, 133.1 ± 11.9, P b 0.0001). In addition,
the incidence ofmorningHT in obese diabetic patients was signiﬁcantly
higher than the others (73.0%, 49.9%, P b 0.0001). Conclusion: Morning
hypertension is frequent in diabetic or obese patients.
doi:10.1016/j.lfs.2013.12.099
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